Patents by Inventor Pei Qi

Pei Qi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240088392
    Abstract: Provided is an electrode mixture including: an electrode active material; an organic solvent; a binder; and an additive; wherein the binder contains a fluorine-containing copolymer containing a vinylidene fluoride unit and a fluorinated monomer unit, provided that the vinylidene fluoride unit is excluded from the fluorinated monomer unit; the additive is a polymer material containing the following repeating unit: —[CH2—CHR]— wherein R is a chain or cyclic amide group, a nitrile group, or a substituted alkyl group formed by substituting at least one of hydrogen atoms of an alkyl group having 1 to 4 carbon atoms with a chain or cyclic amide group or a nitrile group; a content of the binder is 0.1 to 1.6 parts by mass with respect to 100 parts by mass of the electrode active material; and a content of the additive is 0.001 to 0.2 parts by mass with respect to 100 parts by mass of the electrode active material.
    Type: Application
    Filed: March 3, 2023
    Publication date: March 14, 2024
    Applicants: DAIKIN INDUSTRIES, LTD., DAIKIN FLUOROCHEMICALS (CHINA) CO., LTD.
    Inventors: Kanako ARAI, Ryouichi YANO, Yuki YOTSUMOTO, Pei Qi LIU, En Hao ZHANG
  • Publication number: 20240084275
    Abstract: Disclosed herein, in certain embodiments, are methods of inducing cell cycle arrest, apoptosis, cell death, or a combination thereof, in a cell or population of cells. Also disclosed herein are methods of treating a disease or condition in an individual in need thereof comprising inducing cell cycle arrest, apoptosis, cell death, or a combination thereof in a population of cells in the individual. The cell or population of cells may comprise a nucleic acid sequence associated with a disease or condition, including an autoimmune disease, cancer, or an infectious disease. The methods described herein generally comprise contacting cells with a CRISPR-associated protein and a guide nucleic acid.
    Type: Application
    Filed: June 16, 2023
    Publication date: March 14, 2024
    Inventors: Lucas Benjamin HARRINGTON, Pei-Qi LIU, Subhadra JAYARAMAN RUKMINI
  • Patent number: 11928132
    Abstract: Provided are a database processing method and apparatus, and a computer readable storage medium. The database processing method comprises: after a lock wait is generated, writing lock wait related information into a lock wait log.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: March 12, 2024
    Assignee: XI'AN ZHONGXING NEW SOFTWARE CO., LTD.
    Inventors: Pin Lin, Yan Ding, Qinyuan Lu, Chen Qi, Yifang Yu, Pei Zhao
  • Publication number: 20230357735
    Abstract: Provided herein, in certain embodiments, are programmable nucleases, guide nucleic acids, and complexes thereof. Certain programmable nucleases provided herein comprise a RuvC domain. Also provided herein are nucleic acids encoding said programmable nucleases and guide nucleic acids. Also provided herein are methods of genome editing, methods of regulating gene expression, and methods of detecting nucleic acids with said programmable nucleases and guide nucleic acids.
    Type: Application
    Filed: June 3, 2021
    Publication date: November 9, 2023
    Inventors: Lucas Benjamin HARRINGTON, William Douglass WRIGHT, Pei-Qi LIU, Benjamin Julius RAUCH, Wiputra Jaya HARTONO, Bridget Ann Paine MCKAY, Danuta Sastre PHIPPS, Yuxuan ZHENG, Nerea SANVISENS, Sean CHEN, David PAEZ-ESPINO
  • Publication number: 20230265678
    Abstract: A universal adaptor for door handle, operable to be universally assembled in a polygonal assembling groove of one of multiple types of handles, so that the above-mentioned handle forms a panel-like lock handle and is locked to a panel lock, and includes a lock portion and a universal extension portion. The lock portion is formed with at least one lock hole corresponding to the panel lock. The universal extension portion is connected to the lock portion and extends along an extension direction to form a polygonal rod structure, and a catching-type fit relationship is formed between the polygonal rod structure and the polygonal assembling groove. The present disclosure can achieve the functions and effects of universally assembling in polygonal assembling grooves of handles with different appearances and thereby enabling the handles to be locked to panel locks.
    Type: Application
    Filed: April 25, 2022
    Publication date: August 24, 2023
    Inventors: JUNG-CHUNG CHEN, PEI-QI CHEN
  • Publication number: 20230167454
    Abstract: Provided herein, in certain embodiments, are programmable nucleases, guide nucleic acids, and complexes thereof. Certain programmable nucleases provided herein comprise a RuvC domain. Also provided herein are nucleic acids encoding said programmable nucleases and guide nucleic acids. Also provided herein are methods of genome editing, methods of regulating gene expression, and methods of detecting nucleic acids with said programmable nucleases and guide nucleic acids.
    Type: Application
    Filed: August 11, 2022
    Publication date: June 1, 2023
    Inventors: Lucas Benjamin HARRINGTON, William Douglass WRIGHT, Pei-Qi LIU, Benjamin Julius RAUCH, Wiputra Jaya HARTONO, Bridget Ann Paine MCKAY, Danuta Sastre PHIPPS, Yuxuan ZHENG, Nerea SANVISENS, Sean CHEN, David PAEZ-ESPINO
  • Patent number: 11214610
    Abstract: Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subunit proteins, which may or may not be secreted, with a higher yield and decreased production of undesired side-products. In exemplary embodiments, the transformed cells are a yeast, e.g., methylotrophic yeast such as Pichia pastoris.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: January 4, 2022
    Assignee: H. LUNDBECK A/S
    Inventors: Patricia Dianne McNeill, Leon F. Garcia-Martinez, Nicole Janson, Gary Lesnicki, Pei Qi, John A. Latham
  • Publication number: 20210070830
    Abstract: The present disclosure provides a system for regulating expression of a target polynucleotide in a cell. The system may comprise a chimeric polypeptide comprising a gene modulating polypeptide fused in-frame with a heterologous nuclear localization domain. The heterologous nuclear localization domain may be operable to translocate the chimeric polypeptide to a cell nucleus upon activation by an active cellular signaling pathway. The cellular signaling pathway may be inducible in response to an extracellular signal. In response to the extracellular signal, the chimeric polypeptide may localize to the cell nucleus and the gene modulating polypeptide may regulate expression of a target polynucleotide in the cell nucleus.
    Type: Application
    Filed: September 18, 2020
    Publication date: March 11, 2021
    Inventors: Pei-Qi LIU, Jianbin WANG
  • Publication number: 20200157534
    Abstract: The present disclosure provides systems, methods, and compositions for conditionally regulating expression of a target gene. Aspects of the present disclosure utilize intracellular signal transduction pathways to regulate the expression of a gene (e.g., transgene, exogenous gene, endogenous gene).
    Type: Application
    Filed: January 10, 2020
    Publication date: May 21, 2020
    Inventors: Jianbin WANG, Bing WANG, Pei-Qi LIU
  • Patent number: 10072066
    Abstract: Methods and compositions for treatment of a beta thalessemia are provided.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: September 11, 2018
    Assignee: Sangamo Therapeutics, Inc.
    Inventors: Pei-Qi Liu, Andreas Reik, Lei Zhang
  • Patent number: 9388426
    Abstract: Disclosed herein are methods and compositions for inactivating a glutamine synthetase (GS) gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: July 12, 2016
    Assignee: Sangamo BioSciences, Inc.
    Inventors: Pei-Qi Liu, Jeffrey C. Miller
  • Patent number: 9197086
    Abstract: In one implementation, an input power management component receives an input power, and determines whether an input current and voltage satisfies predetermined thresholds. A boost component generates a boost output voltage using the input voltage if the input current satisfies a predetermined current threshold, and a step-down charging component converts the boost output voltage to a voltage for charging a battery and system power management.
    Type: Grant
    Filed: April 30, 2012
    Date of Patent: November 24, 2015
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Pei-Qi Zhou, Wei Yan
  • Publication number: 20150218253
    Abstract: Methods and compositions for treatment of a beta thalessemia are provided.
    Type: Application
    Filed: February 2, 2015
    Publication date: August 6, 2015
    Inventors: Pei-Qi Liu, Andreas Reik, Lei Zhang
  • Publication number: 20150087067
    Abstract: Disclosed herein are methods and compositions for inactivating a glutamine synthetase (GS) gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
    Type: Application
    Filed: November 24, 2014
    Publication date: March 26, 2015
    Inventors: Pei-Qi Liu, Jeffrey C. Miller
  • Patent number: 8689022
    Abstract: Methods of and apparatus for controlling power drawn by an appliance through a USB port. The method includes limiting any electrical current drawn by an appliance to one of seven levels according to whether the data lines receive a bias from a power line, the data lines are in electrical communication with each other, and the power source includes a host computing device, or according to logic and voltage levels of the data lines when any of the pull-down resistor and the current and voltage sources are connected or not connected to the D+ data line. The apparatus includes a controller programmed to selectively connect a pull-down resistor, a current source, and a voltage source to a D+ data line and to limit any electrical current drawn from a power source to one of the seven levels according to voltage levels on the D+ data line and a D? data line.
    Type: Grant
    Filed: August 30, 2011
    Date of Patent: April 1, 2014
    Assignee: Qualcomm Incorporated
    Inventor: Pei-Qi Zhou
  • Publication number: 20130285596
    Abstract: In one implementation, an input power management component receives an input power, and determines whether an input current and voltage satisfies predetermined thresholds. A boost component generates a boost output voltage using the input voltage if the input current satisfies a predetermined current threshold, and a step-down charging component converts the boost output voltage to a voltage for charging a battery and system power management.
    Type: Application
    Filed: April 30, 2012
    Publication date: October 31, 2013
    Inventors: Pei-Qi Zhou, Wei Yan
  • Publication number: 20130164785
    Abstract: Disclosed herein are methods and compositions for inactivating a glutamine synthetase (GS) gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
    Type: Application
    Filed: September 6, 2012
    Publication date: June 27, 2013
    Inventors: Pei-Qi Liu, Jeffrey C. Miller
  • Publication number: 20130054983
    Abstract: Methods of and apparatus for controlling power drawn by an appliance through a USB port. The method includes limiting any electrical current drawn by an appliance to one of seven levels according to whether the data lines receive a bias from a power line, the data lines are in electrical communication with each other, and the power source includes a host computing device, or according to logic and voltage levels of the data lines when any of the pull-down resistor and the current and voltage sources are connected or not connected to the D+ data line. The apparatus includes a controller programmed to selectively connect a pull-down resistor, a current source, and a voltage source to a D+ data line and to limit any electrical current drawn from a power source to one of the seven levels according to voltage levels on the D+ data line and a D? data line.
    Type: Application
    Filed: August 30, 2011
    Publication date: February 28, 2013
    Inventor: Pei-Qi Zhou
  • Publication number: 20120277408
    Abstract: Methods for producing heterologous multi-subunit proteins in transformed cells are disclosed. In particular, the present disclosure provides improved methods of producing multi-subunit proteins, including antibodies and other multi-subunit proteins, which may or may not be secreted, with a higher yield and decreased production of undesired side-products. In exemplary embodiments, the transformed cells are a yeast, e.g., methylotrophic yeast such as Pichia pastoris.
    Type: Application
    Filed: May 8, 2012
    Publication date: November 1, 2012
    Applicant: Alderbio Holdings LLC
    Inventors: Patricia Dianne McNeill, Leon F. Garcia-Martinez, Nicole Janson, Gary Lesnicki, Pei Qi, John A. Latham
  • Patent number: 8153399
    Abstract: Disclosed herein are methods and compositions for inactivating a glutamine synthetase (GS) gene, using fusion proteins comprising a zinc finger protein and a cleavage domain or cleavage half-domain. Polynucleotides encoding said fusion proteins are also provided, as are cells comprising said polynucleotides and fusion proteins.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: April 10, 2012
    Assignee: Sangamo Biosciences, Inc.
    Inventors: Pei-Qi Liu, Jeffrey C. Miller